This page includes the latest FDA filings for Clovis Oncology Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | CLVS | DUNS 830871518 |
Device Company | Device | Date |
---|---|---|
Clovis Oncology, Inc. | Prescription Medication | 2024-02-23 |
Clovis Oncology, Inc. | Prescription Medication | 2023-11-25 |
Clovis Oncology, Inc. | Prescription Medication | 2022-12-29 |
Clovis Oncology, Inc. | Prescription Medication | 2022-06-18 |
Clovis Oncology, Inc. | Prescription Medication | 2021-10-08 |
Clovis Oncology, Inc. | Prescription Medication | 2020-10-13 |
Clovis Oncology, Inc. | Prescription Medication | 2020-05-22 |
Clovis Oncology, Inc. | Prescription Medication | 2018-04-12 |
Clovis Oncology, Inc. | Rubraca | 2017-05-01 |
Clovis Oncology, Inc. | Rubraca | 2016-12-19 |
Clovis Oncology, Inc. | Rubraca | 2016-12-19 |
CLOVIS ONCOLOGY INC | 0000-00-00 00:00:00 |
NCAGE Code | 63JV0 | CLOVIS ONCOLOGY, INC.!DBA CLOVIS ONCOLOGY |
CAGE Code | 63JV0 | CLOVIS ONCOLOGY, INC. CLOVIS ONCOLOGY |
S.A.M. Registration | 63JV0 [830871518] | CLOVIS ONCOLOGY, INC. CLOVIS ONCOLOGY |
SEC | 0001466301 | Clovis Oncology, Inc. of DELAWARE |